Your browser doesn't support javascript.
loading
[Rethinking the marketing strategy of anti-tumor drugs by single-arm trials supported].
Tang, L; Zhou, M; Xia, L; Hao, R M; Tong, X; Chen, D M; Song, Y Y; Zhao, X; Zhang, H; Hu, W J; Zou, L M; Du, Y; Qi, Y L; Chen, X M; Yang, Z M.
Afiliación
  • Tang L; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Zhou M; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Xia L; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Hao RM; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Tong X; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Chen DM; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Song YY; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Zhao X; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Zhang H; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Hu WJ; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Zou LM; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Du Y; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Qi YL; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Chen XM; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
  • Yang ZM; Center for Drug Evaluation, National Medical Products Administration of China, Beijing 100022, China.
Zhonghua Zhong Liu Za Zhi ; 44(6): 587-592, 2022 Jun 23.
Article en Zh | MEDLINE | ID: mdl-35754235
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China